Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

112.09 +2.45 (+2.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Gilead Sciences

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
43 44 Next >
Is Gilead Sciences a Good Stock to Buy Now?
Gilead Sciences' breast cancer drug, Trodelvy, just took a big step forward. 
Via The Motley Fool
Market Rally Powers Higher On Tame Fed, Meta Earnings; Apple, Google, Amazon In Focus: Weekly Review
The major indexes continued to run despite mixed-to-weak earnings. 
Via Investor's Business Daily
Gilead Sciences' Trovelvy Scores FDA Approval For Advanced/Metastatic Breast Cancer Setting
Via Benzinga
'Risk Of Overheating': 4 Experts On Hot January Jobs Report, How The Fed Will React
The SPDR S&P 500 ETF Trust (NYSE: SPY) traded lower Friday after the Labor Department reported blowout U.S. jobs market numbers from January. 
Via Benzinga
Gilead Issues Unexpectedly Bullish Outlook After Cancer Drug Sales Rocket
The company posted another massive quarter for cancer treatment sales. 
Via Investor's Business Daily
Earnings Outlook For Gilead Sciences
Via Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have $400 Today
Via Benzinga
Nasdaq Futures Deflate As Apple Leads Tech Disappointments: Traders Look To Jobs Data For Mitigating Impact
Trading in the U.S. index futures suggests stocks may end a solidly positive week on a negative note. That said, the data-dependency of the Fed places the onus of providing trading cues to each... 
Via Benzinga
Is Gilead Sciences Stock a Screaming Buy After Its Strongest Results in 7 Years?
Gilead's strongest growth since 2015 comes with an asterisk. 
Via The Motley Fool
Gilead Sciences (GILD) Q4 2022 Earnings Call Transcript
GILD earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Why Gilead Sciences Stock Is Trading Higher After Hours
Gilead Sciences Inc (NASDAQ: GILD) shares are trading higher in Thursday's after-hours session after the company reported  
Via Benzinga
Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line?
The index futures point to a mixed opening on Thursday, as tech earnings continue to be encouraging. 
Via Benzinga
Could Gilead Sciences Stock Help You Become a Millionaire?
Does Gilead have enough growth potential to become a market-beating investment? 
Via The Motley Fool
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new... 
Via Benzinga
These 3 Healthcare Stocks With Over 3% Dividend Yields Are Recommended By Benzinga's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
3 Smart Stocks to Buy if a Recession Is on the Way
Their products will enjoy strong demand regardless of what happens with the economy. 
Via The Motley Fool
16 Analysts Have This to Say About Gilead Sciences
Via Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have $400 Today
Via Benzinga
This New Drug Could Be Gilead Sciences' Growth Catalyst
Another potential blockbuster drug in Gilead's hands. 
Via The Motley Fool
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
With a full week of earnings behind us, it’s time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed. 
Via Benzinga
3 Stocks That Beat the S&P During the Great Recession
These stocks could be safe places to store your money if a recession takes place this year. 
Via The Motley Fool
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing. 
Via Talk Markets
Peering Into Gilead Sciences's Recent Short Interest
Gilead Sciences's (NASDAQ:GILD) short percent of float has fallen 15.71% since its last report. The company recently reported that it has 14.76 million shares sold short, which is 1.18% of all regular... 
Via Benzinga
2 Unstoppable Stocks That Could Beat the Market Again In 2023
Thankfully, it's not too late to buy these stocks. 
Via The Motley Fool
Can The No. 1 Pharma Stock, Merck, Continue Its Blazing Run In 2023?
Merck has a number of efforts in the works to help avoid a Keytruda generics pitfall. 
Via Investor's Business Daily
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
Which of these companies is better able to replace declining COVID-19-related sales? 
Via The Motley Fool
FTX Exchange's Assets Worth $3.5B Held By Bahamian Regulators, Italy PM To Meet Intel Over Chip Investment, New Oral COVID Antiviral Might Be Better Than Pfizer's Paxlovid: Today's Top Stories
Reuters 
Via Benzinga
New Oral COVID-19 Antiviral Might Be Better Than Pfizer's Paxlovid With Faster Recovery, Fewer Side Effects, Data Shows
A study in China shows that a remdesivir analog, dubbed VV116, is as effective as Pfizer Inc's (NYSE: PFE) oral COVID-19 pill. 
Via Benzinga
3 High-Yielding Dividend Stocks That Could See Hikes in January
These stocks all pay more than 3% in dividends. 
Via The Motley Fool
Gilead Sciences Acquires Jounce Therapeutics Cancer Immunotherapy Program
Via Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
43 44 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.